BitterSweetMarkets
Short

GNCA Performed well Today off the back of data from its trial...

NASDAQ:GNCA   GENOCEA BIOSCIENCES INC
49 0 1
GNCA             Stock was up almost 400 pips today on heavy trading volume after the company reported positive efficacy data from a Phase 2 trial for its genital herpes treatment. It rallied until it exhausted itself at Oct             2014 multiple resistance area (7.75,8.25 respectively). Indicators are signaling a Pullback is imminent, prices could consolidate around these levels for a while and on from that period will help determine direction. Although today does look promising unfortunately in my opinion on researching this company it does have a number of negative factors which could well outweigh any positive news and data that comes out here and there. Also the history of the stock's performance isn't great, before todays             data the stock was in a downtrend...that can't be ignored.
Trade closed: target reached: I Shorted this at the open and closed my position at 615 as we go into the weekend, however more Downside is Likely in my opinion.
United States
United Kingdom
India
Deutschland
España
France
Việt Nam
Italia
Polska
Brasil
Россия
Türkiye
Indonesia
Malaysia
日本
한국
简体
繁體
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing Support Priority Support Report Issue Ideas Published Followers Following Private Messages Chat Sign Out